Recommended Medium: It is recommended to use HematoGro Medium (HeGM, Cat. no. SC5501) for short-term maintenance of RBMMC in vitro.
Product Use: RBMMC are for research use only. They are not approved for human or animal use, or for application in in vitro diagnostic procedures.
Storage: Upon receiving, directly and immediately transfer the cells from dry ice to liquid nitrogen and keep the cells in liquid nitrogen until they are needed for experiments.
Shipping: Dry ice.
References: [1] Henrich D, Verboket R, Schaible A, Kontradowitz K, Oppermann E, Brune J, Nau C, Meier S, Bonig H, Marzi I, Seebach C. (2015) “Characterization of bone marrow mononuclear cells on biomaterials for bone tissue engineering in vitro.” Biomed Res Int. 10: 1-12.
[2] Savitz S, Misra V, Kasam M, Juneja H., Cox C, Alderman S, et al. (2011). “Intravenous autologous bone marrow mononuclear cells for ischemic stroke.” Ann Neurol. 70:59–69.
[3]Fotino C, Ricordi C, Lauriola V, Alejandro R, Pileggi A. (2010) “Bone marrow-derived stem cell transplantation for the treatment of insulin-dependent diabetes.” Rev Diabet Stud. 7(2): 144-157.
[4] Arnous S, Mozid A, Martin J, Mathur A. (2012) “Bone marrow mononuclear cells and acute myocardial infarction.” Stem Cell Res. 3(1): 2-10.